- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x CYN: CYANIDE ION(Non-covalent)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
TGL.7: 15 residues within 4Å:- Chain A: V.350, T.354, Y.379, N.422, F.426, H.429, F.430, L.433
- Chain B: L.7, G.8, L.28, V.31, F.32, S.35
- Chain I: R.43
14 PLIP interactions:5 interactions with chain A, 2 interactions with chain I, 7 interactions with chain B- Hydrophobic interactions: A:V.350, A:T.354, A:F.426, A:H.429, A:F.430, B:L.7, B:V.31, B:F.32, B:F.32
- Water bridges: I:R.43, B:G.8, B:F.9
- Salt bridges: I:R.43, B:H.24
TGL.49: 19 residues within 4Å:- Chain A: W.334, M.339, L.342, G.343, F.414, A.415, V.419
- Chain B: L.39, I.42, S.43, T.47
- Chain D: R.70, E.74, W.75, V.78, M.83, I.86
- Chain I: R.16
- Ligands: EDO.17
12 PLIP interactions:6 interactions with chain A, 3 interactions with chain D, 3 interactions with chain B- Hydrophobic interactions: A:W.334, A:W.334, A:L.342, A:A.415, A:V.419, D:V.78, B:L.39, B:I.42, B:T.47
- Salt bridges: A:K.411
- Hydrogen bonds: D:T.72, D:E.74
TGL.70: 26 residues within 4Å:- Chain A: F.2, T.17, L.18, L.20, L.21, F.22, W.25, W.81, P.106, F.109, L.110, L.113, F.393, F.400, S.401, I.472
- Chain L: I.10, P.11, F.12, R.19, M.23, M.24, F.27, F.28, I.38
- Ligands: HEA.1
23 PLIP interactions:14 interactions with chain A, 9 interactions with chain L- Hydrophobic interactions: A:F.2, A:T.17, A:L.18, A:L.20, A:L.21, A:F.22, A:W.25, A:W.25, A:W.81, A:F.109, A:F.109, A:L.113, A:F.400, A:I.472, L:I.10, L:F.12, L:F.12, L:M.23, L:F.27, L:F.27, L:F.28, L:F.28, L:I.38
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
PGV.8: 10 residues within 4Å:- Chain A: N.406, T.408, W.409, I.412
- Chain D: A.81, F.84
- Chain K: F.4, H.5
- Chain M: P.12, Q.15
17 PLIP interactions:5 interactions with chain A, 4 interactions with chain D, 5 interactions with chain K, 3 interactions with chain M- Hydrophobic interactions: A:T.408, A:W.409, A:W.409, A:I.412, D:A.81, D:F.84, D:F.84, D:F.84, K:F.4, K:F.4, K:F.4, M:P.12, M:P.12
- Hydrogen bonds: A:T.408
- Water bridges: K:F.4, M:A.3
- Salt bridges: K:H.5
PGV.9: 27 residues within 4Å:- Chain A: F.94, P.95, R.96, M.97, M.100, F.148, H.151, P.200
- Chain C: H.7, V.9, G.18, A.22, T.26, N.48, T.51, M.52, W.55, W.56, V.59, E.62, H.69, L.77, G.80, F.84, E.88, F.91
- Ligands: PEK.35
16 PLIP interactions:7 interactions with chain A, 9 interactions with chain C- Hydrophobic interactions: A:F.148, A:P.200, C:A.22, C:T.26, C:T.51, C:W.55, C:W.55, C:W.55, C:W.56, C:F.91
- Hydrogen bonds: A:R.96, A:R.96, A:M.97, C:W.55
- Water bridges: A:A.93
- Salt bridges: A:R.96
PGV.37: 26 residues within 4Å:- Chain C: M.49, M.52, W.56, V.59, I.60, S.63, T.64, H.69, L.77, M.81, F.84, F.91, F.201, H.205, I.208, T.211, F.212, R.219, H.224, F.225, T.226, H.229, H.230, F.231, G.232
- Ligands: CDL.39
30 PLIP interactions:28 interactions with chain C, 2 interactions with chain F- Hydrophobic interactions: C:W.56, C:W.56, C:W.56, C:W.56, C:W.56, C:I.60, C:F.84, C:F.91, C:F.201, C:I.208, C:I.208, C:I.208, C:T.211, C:F.212, C:F.212, C:F.212
- Hydrogen bonds: C:S.63, C:R.219, C:F.231, C:G.232
- Water bridges: C:S.63, C:Q.74, C:R.219, C:H.229, C:H.229, F:Q.12, F:E.17
- Salt bridges: C:R.219, C:R.219, C:H.229
PGV.38: 12 residues within 4Å:- Chain A: F.237, D.298
- Chain C: V.89, T.93, W.97, Y.100, H.101, L.104, A.105
- Chain H: N.16, N.18
- Ligands: CHD.33
12 PLIP interactions:2 interactions with chain A, 5 interactions with chain C, 5 interactions with chain H- Hydrophobic interactions: A:F.237, C:V.89, C:T.93, C:W.97, C:W.97, C:W.97
- Hydrogen bonds: A:D.298, H:N.16
- Water bridges: H:N.18, H:N.18, H:N.18, H:N.18
- 42 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.10: 7 residues within 4Å:- Chain A: Y.19, M.71, P.72, S.101, L.105, S.156, S.157
Ligand excluded by PLIPEDO.11: 6 residues within 4Å:- Chain A: Q.52, A.120, A.137, H.138, A.139
- Ligands: EDO.22
Ligand excluded by PLIPEDO.12: 7 residues within 4Å:- Chain A: Y.260, Y.261, V.394, H.395, V.485, W.494
- Chain M: I.1
Ligand excluded by PLIPEDO.13: 8 residues within 4Å:- Chain A: L.483, T.484, V.485, T.488, W.494, G.497, C.498
- Chain D: Y.8
Ligand excluded by PLIPEDO.14: 9 residues within 4Å:- Chain A: R.5, N.11, K.13, D.14, W.81, P.499, P.500, Y.502
- Chain L: N.9
Ligand excluded by PLIPEDO.15: 6 residues within 4Å:- Chain A: H.256, T.259, K.265, T.490, N.491
- Ligands: EDO.59
Ligand excluded by PLIPEDO.16: 6 residues within 4Å:- Chain A: E.507
- Chain C: T.3
- Chain F: P.30, N.32, P.50, R.56
Ligand excluded by PLIPEDO.17: 4 residues within 4Å:- Chain A: M.423
- Chain D: I.86
- Chain K: W.24
- Ligands: TGL.49
Ligand excluded by PLIPEDO.18: 5 residues within 4Å:- Chain A: K.265, T.489
- Chain F: I.70, P.83, S.84
Ligand excluded by PLIPEDO.19: 6 residues within 4Å:- Chain A: G.269, Y.270, M.271, G.272
- Chain B: E.62
- Ligands: CHD.25
Ligand excluded by PLIPEDO.20: 6 residues within 4Å:- Chain A: K.333, W.334, S.335, P.336, D.407, K.411
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain A: P.131, D.221, P.222
Ligand excluded by PLIPEDO.22: 4 residues within 4Å:- Chain A: L.136, A.137
- Chain B: Q.103
- Ligands: EDO.11
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: N.496, T.504, F.505, E.506, E.507
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: P.106, L.110
- Chain C: L.20
Ligand excluded by PLIPEDO.27: 2 residues within 4Å:- Chain B: L.135, F.206
Ligand excluded by PLIPEDO.28: 2 residues within 4Å:- Chain B: E.157
- Ligands: EDO.44
Ligand excluded by PLIPEDO.29: 7 residues within 4Å:- Chain A: Y.447
- Chain B: M.1, A.2, Q.10, L.136, P.166, Y.193
Ligand excluded by PLIPEDO.30: 5 residues within 4Å:- Chain B: Q.103, W.104, Y.105, Y.121, N.203
Ligand excluded by PLIPEDO.31: 5 residues within 4Å:- Chain B: G.177
- Chain C: E.109
- Chain H: W.62, W.66
- Ligands: EDO.44
Ligand excluded by PLIPEDO.42: 3 residues within 4Å:- Chain C: G.139, T.143, H.241
Ligand excluded by PLIPEDO.43: 5 residues within 4Å:- Chain C: N.10, P.11
- Chain J: G.17, L.18, P.19
Ligand excluded by PLIPEDO.44: 7 residues within 4Å:- Chain A: P.222, A.223
- Chain B: G.177
- Chain C: E.109
- Chain H: W.62
- Ligands: EDO.28, EDO.31
Ligand excluded by PLIPEDO.45: 3 residues within 4Å:- Chain C: H.1, Q.2, H.68
Ligand excluded by PLIPEDO.46: 4 residues within 4Å:- Chain C: L.125, Y.251, W.256
- Ligands: CDL.62
Ligand excluded by PLIPEDO.47: 7 residues within 4Å:- Chain C: W.144, S.148, H.156
- Chain F: S.2
- Chain G: A.13, R.14, R.17
Ligand excluded by PLIPEDO.50: 6 residues within 4Å:- Chain D: K.118, L.121, D.122, W.135, N.140
- Chain K: P.45
Ligand excluded by PLIPEDO.51: 6 residues within 4Å:- Chain D: Y.19, D.23
- Chain E: W.23, R.26, K.27, N.30
Ligand excluded by PLIPEDO.52: 7 residues within 4Å:- Chain A: L.495
- Chain D: Y.8, A.9, L.10, P.11
- Chain F: F.72, W.73
Ligand excluded by PLIPEDO.54: 3 residues within 4Å:- Chain E: Y.14, K.17, E.24
Ligand excluded by PLIPEDO.55: 4 residues within 4Å:- Chain E: R.49, R.52, R.53, L.92
Ligand excluded by PLIPEDO.57: 6 residues within 4Å:- Chain A: Y.510
- Chain F: P.36, K.37, T.39, N.47, L.48
Ligand excluded by PLIPEDO.58: 6 residues within 4Å:- Chain C: P.71, Q.74, N.228, H.229
- Chain F: D.9, E.17
Ligand excluded by PLIPEDO.59: 7 residues within 4Å:- Chain A: T.489, T.490
- Chain F: S.67, T.68, V.69, W.71
- Ligands: EDO.15
Ligand excluded by PLIPEDO.60: 3 residues within 4Å:- Chain F: F.72, Q.80, R.81
Ligand excluded by PLIPEDO.63: 2 residues within 4Å:- Chain G: A.1, A.3
Ligand excluded by PLIPEDO.64: 6 residues within 4Å:- Chain C: G.118
- Chain G: A.46, F.47, I.48, L.53, R.54
Ligand excluded by PLIPEDO.66: 4 residues within 4Å:- Chain H: D.29, R.32, C.33, Y.50
Ligand excluded by PLIPEDO.69: 4 residues within 4Å:- Chain J: A.6, Q.9, K.10, Q.13
Ligand excluded by PLIPEDO.71: 3 residues within 4Å:- Chain A: L.113, M.117
- Chain L: I.38
Ligand excluded by PLIPEDO.72: 5 residues within 4Å:- Chain L: G.7, K.8, I.10, F.12, S.13
Ligand excluded by PLIPEDO.75: 5 residues within 4Å:- Chain A: T.46, L.47
- Chain D: V.100
- Chain M: D.38, K.41
Ligand excluded by PLIP- 5 x CHD: CHOLIC ACID(Non-covalent)
CHD.25: 7 residues within 4Å:- Chain A: M.271, G.272, W.275
- Chain B: E.62, T.63, T.66
- Ligands: EDO.19
7 PLIP interactions:3 interactions with chain B, 4 interactions with chain A- Hydrophobic interactions: B:T.66, A:M.271, A:W.275, A:W.275, A:W.275
- Hydrogen bonds: B:E.62, B:T.63
CHD.33: 8 residues within 4Å:- Chain A: H.233, W.288, D.300, T.301, Y.304
- Chain C: W.97, H.101
- Ligands: PGV.38
10 PLIP interactions:7 interactions with chain A, 3 interactions with chain C- Hydrophobic interactions: A:W.288, A:Y.304, A:Y.304, C:W.97
- Hydrogen bonds: A:T.301, C:W.97
- Water bridges: A:D.300, A:T.301
- Salt bridges: A:H.233, C:H.101
CHD.40: 7 residues within 4Å:- Chain C: R.154, L.158, Q.159, F.162, F.217, L.221
- Chain J: F.1
9 PLIP interactions:7 interactions with chain C, 2 interactions with chain J- Hydrophobic interactions: C:L.158, C:F.162, C:F.162, C:F.162, C:F.217, C:L.221, J:F.1
- Salt bridges: C:R.154
- Hydrogen bonds: J:F.1
CHD.68: 7 residues within 4Å:- Chain A: I.3, L.7
- Chain J: Y.32, R.33, M.36, T.37, L.40
4 PLIP interactions:3 interactions with chain J, 1 interactions with chain A- Hydrophobic interactions: J:Y.32, J:R.33, A:I.3
- Hydrogen bonds: J:R.33
CHD.73: 6 residues within 4Å:- Chain L: W.18, L.21, A.22
- Chain M: E.14, I.17, V.21
2 PLIP interactions:2 interactions with chain M- Hydrophobic interactions: M:I.17
- Hydrogen bonds: M:E.14
- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 5 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)
DMU.32: 4 residues within 4Å:- Chain B: H.26, I.30, L.33
- Chain I: K.36
4 PLIP interactions:2 interactions with chain I, 2 interactions with chain B- Hydrogen bonds: I:K.36, I:K.36
- Hydrophobic interactions: B:L.33
- Salt bridges: B:H.26
DMU.41: 13 residues within 4Å:- Chain A: L.110, A.114, L.145
- Chain C: S.27, M.31, F.35
- Chain J: Y.45, S.46, Y.48, C.49, W.52, K.58
- Ligands: DMU.48
11 PLIP interactions:5 interactions with chain J, 3 interactions with chain A, 3 interactions with chain C- Hydrogen bonds: J:Y.45, J:Y.45, J:K.58, J:K.58
- Water bridges: J:Y.48
- Hydrophobic interactions: A:L.110, A:A.114, A:L.145, C:M.31, C:F.35, C:F.35
DMU.48: 10 residues within 4Å:- Chain C: N.36, S.37, T.39, I.43
- Chain J: T.37, L.38, G.41, G.42, Y.45
- Ligands: DMU.41
11 PLIP interactions:4 interactions with chain J, 7 interactions with chain C- Hydrophobic interactions: J:L.38, J:Y.45, J:Y.45, C:I.43
- Hydrogen bonds: J:Y.45, C:N.36, C:N.36, C:N.36, C:S.37, C:S.37, C:S.37
DMU.65: 4 residues within 4Å:- Chain C: W.32, M.38, L.41
- Chain G: G.63
4 PLIP interactions:1 interactions with chain G, 3 interactions with chain C- Hydrogen bonds: G:G.63
- Hydrophobic interactions: C:W.32, C:W.32, C:L.41
DMU.74: 10 residues within 4Å:- Chain A: L.35, F.459
- Chain D: L.92, W.95
- Chain M: L.27, L.28, G.31, W.32, Y.35, H.36
9 PLIP interactions:3 interactions with chain D, 3 interactions with chain M, 3 interactions with chain A- Hydrophobic interactions: D:L.92, D:W.95, M:L.27, M:L.27, A:L.35, A:F.459, A:F.459
- Water bridges: D:Y.99, M:H.36
- 4 x PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE(Non-covalent)
PEK.34: 9 residues within 4Å:- Chain C: I.82, V.89, T.93, F.96, W.238, H.241, F.242, V.245, F.249
9 PLIP interactions:9 interactions with chain C- Hydrophobic interactions: C:I.82, C:V.89, C:V.89, C:F.96, C:W.238, C:W.238, C:W.238, C:H.241, C:V.245
PEK.35: 27 residues within 4Å:- Chain A: H.151, V.155, A.203, L.210, L.215
- Chain C: W.32, F.33, Q.175, A.176, Y.179, Y.180, A.182, F.184, T.185, I.186, F.196, G.200, F.201, G.203, I.207
- Chain G: W.62, T.68, F.69, F.70, H.71, N.76
- Ligands: PGV.9
22 PLIP interactions:4 interactions with chain A, 9 interactions with chain C, 9 interactions with chain G- Hydrophobic interactions: A:V.155, A:A.203, A:L.210, A:L.215, C:W.32, C:F.33, C:Q.175, C:Y.179, C:I.186, C:F.201, C:F.201, C:I.207, G:W.62, G:F.69
- Hydrogen bonds: C:I.186, G:T.68, G:F.70, G:F.70, G:N.76, G:N.76
- Water bridges: G:F.69, G:F.69
PEK.36: 7 residues within 4Å:- Chain C: Q.159, T.166, Y.170
- Chain G: R.17, F.21, G.22, A.29
7 PLIP interactions:4 interactions with chain C, 3 interactions with chain G- Hydrophobic interactions: C:T.166, C:Y.170, C:Y.170, C:Y.170, G:F.21, G:A.29
- Salt bridges: G:R.17
PEK.61: 1 residues within 4Å:- Chain G: S.2
No protein-ligand interaction detected (PLIP)- 2 x CDL: CARDIOLIPIN(Non-covalent)
CDL.39: 21 residues within 4Å:- Chain C: M.49, L.50, Y.53, W.56, R.57, I.60, R.61, F.65, V.169, S.210, T.211, I.214, V.215, F.218, K.222, H.224
- Chain J: K.8, F.12, T.27, L.31
- Ligands: PGV.37
23 PLIP interactions:3 interactions with chain J, 20 interactions with chain C- Hydrophobic interactions: J:L.31, C:M.49, C:Y.53, C:Y.53, C:Y.53, C:W.56, C:W.56, C:R.57, C:V.169, C:T.211, C:I.214, C:V.215, C:F.218
- Hydrogen bonds: J:D.28, C:Y.53
- Salt bridges: J:K.8, C:R.61, C:K.222, C:K.222, C:H.224
- Water bridges: C:R.57, C:R.57, C:R.61
CDL.62: 19 residues within 4Å:- Chain C: N.123, L.125, L.129, T.132, S.133, L.136, V.140, L.248, Y.251, V.252, W.256
- Chain G: L.23, S.27, L.30, C.31, L.33, N.34, H.38
- Ligands: EDO.46
15 PLIP interactions:9 interactions with chain C, 6 interactions with chain G
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.65 Å
- Oligo State
- hetero-1-1-1-1-1-1-1-1-1-1-1-1-1-mer
- Ligands
- 2 x HEA: HEME-A(Non-covalent)
- 1 x CU: COPPER (II) ION(Non-covalent)
- 1 x MG: MAGNESIUM ION(Non-covalent)
- 1 x NA: SODIUM ION(Non-functional Binders)
- 1 x CYN: CYANIDE ION(Non-covalent)
- 3 x TGL: TRISTEAROYLGLYCEROL(Non-covalent)
- 4 x PGV: (1R)-2-{[{[(2S)-2,3-DIHYDROXYPROPYL]OXY}(HYDROXY)PHOSPHORYL]OXY}-1-[(PALMITOYLOXY)METHYL]ETHYL (11E)-OCTADEC-11-ENOATE(Non-covalent)
- 42 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 5 x CHD: CHOLIC ACID(Non-covalent)
- 1 x CUA: DINUCLEAR COPPER ION(Non-covalent)
- 5 x DMU: DECYL-BETA-D-MALTOPYRANOSIDE(Non-covalent)
- 4 x PEK: (1S)-2-{[(2-AMINOETHOXY)(HYDROXY)PHOSPHORYL]OXY}-1-[(STEAROYLOXY)METHYL]ETHYL (5E,8E,11E,14E)-ICOSA-5,8,11,14-TETRAENOATE(Non-covalent)
- 2 x CDL: CARDIOLIPIN(Non-covalent)